EULAR 2027 - Annual European Congress of Rheumatology, Jun 2027

EULAR 2027 - Annual European Congress of Rheumatology explores advancements in rheumatology, encompassing clinical, research, and public health topics to improve understanding, treatment, and management of rheumatic diseases.

Key Topics

Clinical topics by disease
- Rheumatoid arthritis - comorbidity and clinical aspects
- Rheumatoid arthritis - prognosis, predictors and outcome
- Rheumatoid arthritis - other biologic treatment
- Rheumatoid arthritis - anti-TNF therapy
- SLE, Sjögren`s and APS - treatment
- Rheumatoid arthritis - non biologic treatment
- Vasculitis
- SLE, Sjögren`s and APS - clinical aspects (other than treatment)
- Spondylarthropathies - treatment
- Scleroderma, myositis and related syndromes
- Psoriatic arthritis
- Spondylarthropathies - clinical aspects (other than treatment)
- Osteoporosis
- Osteoarthritis
- Infection-related rheumatic diseases
- Crystal diseases, metabolic bone diseases other than osteoporosis
- Back pain, mechanical musculoskeletal problems, local soft tissue disorders
- Fibromyalgia
- Paediatric rheumatology
- Other orphan diseases
Basic and translational research
- Adaptive immunity (T cells and B cells) in rheumatic diseases
- Genomics, genetic basis of disease and HLA/T cell recognition
- Cytokines and inflammatory mediators
- Innate immunity in rheumatic diseases
- Rheumatoid arthritis - etiology, pathogenesis and animal models
- Cartilage, synovium and osteoimmunology
- SLE, Sjögren`s and APS - etiology, pathogenesis and animal models
- Spondyloarthritis - etiology, pathogenesis and animal models
- Basic science in paediatric rheumatology
- Scleroderma, myosotis and related syndromes - etiology, pathogenesis and animal models
Clinical topics by area of research
- Public health, health services research, and health economics
- Diagnostics and imaging procedures
- Validation of outcome measures and biomarkers
- Epidemiology, risk factors for disease or disease progression
- Education
- Rehabilitation